Market Research Logo

European Market Report for Transcervical Female Sterilization 2016 - MedCore

European Market Report for Transcervical Female Sterilization 2016 - MedCore

The transcervical implant market in Europe currently consists of Bayer AG as the sole competitor offering the Essure® product. Essure® was first developed by the company Conceptus in 2001 and was certified for sale throughout Europe, with the first sale occurring in October 2002. In the United States, Essure® was subsequently approved by the FDA on November 4th, 2002. In April 2013, Bayer AG acquired Conceptus to offer Essure® as part of their contraceptive portfolio. In the United Kingdom, the National Institute for Health and Care Excellence approved Essure® in 2009, the last European country to do so. Since Essure® entered the market in 2002, other notable competitors have been the Ovabloc System and the Adiana procedure. Both of these procedures have since been discontinued.

Female sterilization is a permanent form of birth control, requiring invasive surgery to reverse. Female sterilization prevents ova from coming down the fallopian tubes and blocks fertilization by sperm. There are different procedures to perform female sterilization, including tubal ligation, mechanical blockage with a clip or band, bipolar electrocoagulation or transcervical implants. In this report, only the transcervical implant market is covered.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
1.2.1 Step 1: Project Initiation & Team Selection
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design
1.2.4 Step 4: Performing Primary Research
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
1.2.6 Step 6: Market Forecast and Analysis
1.2.7 Step 7: Identify Strategic Opportunities
1.2.8 Step 8: Final Review and Market Release
1.2.9 Step 9: Customer Feedback and Market Monitoring
COUNTRY PROFILES
2.1 INTRODUCTION
2.1.1.1 Population
2.1.1.2 Median Age
2.1.1.3 GDP Per Capita
2.1.1.4 Price Index
2.2 GERMANY
2.3 FRANCE
2.4 UNITED KINGDOM
2.5 ITALY
2.6 SPAIN
2.7 BENELUX
2.8 SCANDINAVIA
2.9 AUSTRIA
2.10 SWITZERLAND
2.11 PORTUGAL
TRANSCERVICAL FEMALE STERILIZATION MARKET
3.1 INTRODUCTION
3.1.1 Tubal Ligation
3.1.2 Mechanical Sterilization
3.1.3 Bipolar Electrocoagulation
3.1.4 Transcervical Implant
3.2 MARKET ANALYSIS AND FORECAST
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Gynecological Device Market by Segment, Europe, 2012 – 2022
Chart 1 2: Gynecological Device Market Overview, Europe, 2015 & 2022
Chart 2 1: Country Profile, Germany, 2015
Chart 2 2: Country Profile, France, 2015
Chart 2 3: Country Profile, United Kingdom, 2015
Chart 2 4: Country Profile, Italy, 2015
Chart 2 5: Country Profile, Spain, 2015
Chart 2 6: Country Profile, Benelux, 2015
Chart 2 7: Country Profile, Scandinavia, 2015
Chart 2 8: Country Profile, Austria, 2015
Chart 2 9: Country Profile, Switzerland, 2015
Chart 2 10: Country Profile, Portugal, 2015
Chart 3 1: Transcervical Female Sterilization Market, Europe, 2012 – 2022
Chart 3 2: Leading Competitors, Transcervical Female Sterilization Market, Europe, 2015
List of Figures
Figure 1 1: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 3)
Figure 1 2: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 3)
Figure 1 3: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (3 of 3)
Figure 1 4: Companies Researched in this Report, Europe, 2015
Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Europe (1 of 3)
Figure 1 6: Factors Impacting the Gynecological Device Market by Segment, Europe (2 of 3)
Figure 1 7: Factors Impacting the Gynecological Device Market by Segment, Europe (3 of 3)
Figure 1 8: Recent Events in Gynecological Device Market, Europe, 2012 – 2016
Figure 1 9: Gynecological Procedures Covered, Europe, 2015
Figure 1 10: Gynecological Device Markets Covered, Europe, 2015 (1 of 2)
Figure 1 11: Gynecological Device Markets Covered, Europe, 2015 (2 of 2)
Figure 1 12: Key Report Updates (1 of 3)
Figure 1 13: Key Report Updates (2 of 3)
Figure 1 14: Key Report Updates (3 of 3)
Figure 1 15: Version History
Figure 2 1: Population by Country, Europe, 2015
Figure 2 2: Population, Benelux, 2015
Figure 2 3: Scandinavia, Europe, 2015
Figure 2 4: GDP per Capita, Europe, 2015
Figure 3 1: Transcervical Female Sterilization Market, Europe, 2012 – 2022 (€ and US$)
Figure 3 2: Units Sold by Country, Transcervical Female Sterilization Market, Europe, 2012-2022
Figure 3 3: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2012-2022 (€)
Figure 3 4: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2012-2022 (US$)
Figure 3 5: Transcervical Female Sterilization Market by Country, Europe, 2012-2022 (€M)
Figure 3 6: Transcervical Female Sterilization Market by Country, Europe, 2012-2022 (US$M)
Figure 3 7: Drivers and Limiters, Transcervical Female Sterilization Market, Europe, 2015
Figure 3 8: Leading Competitors by Country, Transcervical Female Sterilization Market, Europe, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report